SCHEMBL7668951

SCHEMBL7668951

COC(=O)[C@@H]1CC(=O)C[C@H]1c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 6/20 0.54
SLC6A4 P31645 4/20 0.54
SLC6A2 P23975 3/20 0.54
ATM Q13315 1/20 0.48
POLB P06746 1/20 0.45
TLR2 O60603 1/20 0.44
TLR1 Q15399 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA4 P22748 1/20 0.44
CA7 P43166 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21611427 0.86 SLC6A3 (0.57) SLC6A3SLC6A4SLC6A2ATM
SCHEMBL21611425 0.86 SLC6A3 (0.57) SLC6A3SLC6A4SLC6A2ATM
SCHEMBL22492077 0.86 SLC6A3 (0.53) SLC6A3SLC6A4SLC6A2ATM
SCHEMBL15196794 0.86 SLC6A3 (0.53) SLC6A3SLC6A4SLC6A2ATM
SCHEMBL21611429 0.86 SLC6A3 (0.57) SLC6A3SLC6A4SLC6A2ATM
SCHEMBL22492074 0.86 SLC6A3 (0.53) SLC6A3SLC6A4SLC6A2ATM
SCHEMBL754814 0.83 SLC6A3 (0.52) SLC6A3SLC6A4SLC6A2ATMPOLB
SCHEMBL10267974 0.83 SLC6A3 (0.52) SLC6A3SLC6A4SLC6A2ATMPOLB
SCHEMBL754813 0.83 SLC6A3 (0.52) SLC6A3SLC6A4SLC6A2ATMPOLB
SCHEMBL10292910 0.83 SLC6A3 (0.52) SLC6A3SLC6A4SLC6A2ATMPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6500844-B1 PIPERIDINYL-1-METHYLCYCLOPENTANES AND STEREOISOMERS, USED AS ANTIINFLAMMATORY AND PROPHYLACTIC AGENTS AGAINST ALLERGIC RHINITIS, DERMATITIS, VISION DEFECTS, ASTHMA, ATHRITIS AND FOR PREVENTION OR DELAY OF AQUIRED IMMUNE DIFICIENCY SYNDROME MERCK & CO., INC. 2002-12-31 US disclosed